Ultralife Corporation
DB:ULB Rapport sur les actions
Capitalisation boursière : €122.2m
Ultralife Bilan de santé
Santé financière contrôle des critères 6/6 Ultralife possède un total de capitaux propres de $134.6M et une dette totale de $7.9M, ce qui porte son ratio d'endettement à 5.9%. Son actif total et son passif total sont $172.4M et de $37.8M. L'EBIT de Ultralife est $12.1M ce qui fait que son ratio de couverture des intérêts 6. Elle dispose de liquidités et de placements à court terme de $6.8M.
Informations clés Ratio de couverture des intérêts 6x Argent liquide US$6.77m Fonds propres US$134.63m Total du passif US$37.81m Total des actifs US$172.44m
Mises à jour récentes de la santé financière
Afficher toutes les mises à jour
New minor risk - Share price stability Nov 12
Third quarter 2024 earnings released: EPS: US$0.016 (vs US$0.082 in 3Q 2023) Nov 10
Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024 Oct 24 Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million. Oct 01
Second quarter 2024 earnings released: EPS: US$0.18 (vs US$0.21 in 2Q 2023) Jul 26
Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024 Jul 12
Ultralife Corporation, Annual General Meeting, Jul 16, 2024 May 31
New minor risk - Shareholder dilution Apr 27
First quarter 2024 earnings released: EPS: US$0.18 (vs US$0.021 loss in 1Q 2023) Apr 26
Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024 Apr 12
New minor risk - Earnings quality Apr 02
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Mar 23
Investor sentiment deteriorates as stock falls 16% Mar 19
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Feb 17
Investor sentiment improves as stock rises 31% Feb 16
Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024 Jan 30
Independent Chairman recently bought €103k worth of stock Dec 10
Independent Chairman recently bought €165k worth of stock Dec 01
Independent Chairman recently bought €94k worth of stock Nov 03
Third quarter 2023 earnings released: EPS: US$0.082 (vs US$0.015 loss in 3Q 2022) Oct 27
Investor sentiment deteriorates as stock falls 22% Oct 26
Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023 Oct 13
Independent Chairman recently bought €105k worth of stock Sep 17
Investor sentiment improves as stock rises 29% Aug 23
Investor sentiment improves as stock rises 74% Aug 03
New major risk - Share price stability Jul 29
Second quarter 2023 earnings released: EPS: US$0.21 (vs US$0.032 in 2Q 2022) Jul 28
Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023 Jul 14
Independent Chairman recently bought €367k worth of stock Jun 17
Independent Chairman recently bought €136k worth of stock Jun 03
Ultralife Corporation, Annual General Meeting, Jul 19, 2023 May 31
Independent Chairman recently bought €107k worth of stock May 13
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Apr 06
Independent Chairman recently bought €114k worth of stock Mar 18
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Mar 03
Independent Chairman recently bought €264k worth of stock Dec 11 Ultralife Corporation Announces Executive Changes
Insufficient new directors Nov 16
Third quarter 2022 earnings released: US$0.015 loss per share (vs US$0.036 loss in 3Q 2021) Oct 28
Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022 Oct 14
Independent Chairman recently bought €156k worth of stock Aug 21
Independent Chairman recently bought €457k worth of stock Aug 06
Second quarter 2022 earnings released: EPS: US$0.032 (vs US$0.051 in 2Q 2021) Jul 29 Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022 Jul 15
Independent Chairman recently bought €204k worth of stock Jun 11
Ultralife Corporation, Annual General Meeting, Jul 20, 2022 Jun 01
First quarter 2022 earnings released: US$0.01 loss per share (vs US$0.042 profit in 1Q 2021) Apr 29
Insufficient new directors Apr 27
Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022 Apr 15
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 10
Independent Chairman recently bought €218k worth of stock Mar 05
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Feb 04
Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million. Dec 15
Third quarter 2021 earnings released: US$0.036 loss per share (vs US$0.026 profit in 3Q 2020) Oct 29
Independent Chairman recently bought €168k worth of stock Aug 06
Second quarter 2021 earnings released: EPS US$0.051 (vs US$0.10 in 2Q 2020) Jul 30 Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Defensive Index
Investor sentiment improved over the past week May 19
First quarter 2021 earnings released: EPS US$0.042 (vs US$0.067 in 1Q 2020) May 01
Investor sentiment improved over the past week Mar 30
Investor sentiment improved over the past week Mar 12
New 90-day high: €6.50 Mar 12
Full year 2020 earnings released: EPS US$0.33 (vs US$0.33 in FY 2019) Feb 06
Investor sentiment deteriorated over the past week Jan 30
Ultralife Corporation to Report Q4, 2020 Results on Feb 04, 2021 Jan 22
New 90-day high: €6.40 Nov 24
Market bids up stock over the past week Nov 24
Market bids up stock over the past week Nov 12
Third quarter earnings released Oct 30
New 90-day low: €4.70 Oct 29
Ultralife Corporation to Report Q3, 2020 Results on Oct 29, 2020 Oct 17
New 90-day low: €4.80 Sep 25
New 90-day low - €4.90 Aug 20
New 90-day low - €5.35 Jul 28
Ultralife Corporation to Report Q2, 2020 Results on Jul 30, 2020 Jul 18
Analyse de la situation financière
Passif à court terme: Les actifs à court terme de ULB ( $86.4M ) dépassent ses passifs à court terme ( $26.2M ).
Passif à long terme: Les actifs à court terme de ULB ( $86.4M ) dépassent ses passifs à long terme ( $11.6M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de ULB ( 0.8% ) est considéré comme satisfaisant .
Réduire la dette: Le ratio d'endettement de ULB a été réduit de 16.4% à 5.9% au cours des 5 dernières années.
Couverture de la dette: La dette de ULB est bien couverte par le flux de trésorerie opérationnel ( 131.7% ).
Couverture des intérêts: Les paiements d'intérêts de ULB sur sa dette sont bien couverts par l' EBIT ( 6 x couverture).
Découvrir des entreprises saines Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}